BioCentury
ARTICLE | Company News

Karyopharm management update

February 11, 2013 8:00 AM UTC

Karyopharm Therapeutics Inc., Natick, Mass. Business: Cancer, Inflammation Transitioned: Michael Kauffman to CMO while remaining CEO; and Sharon Shacham to president of R&D, a newly created position, ...